Blog
10-17-2024Cross-posted from: NIAID Newsroom Kidney transplantation from deceased donors with HIV (HIV D+) to recipients...
NIAID
Kidney Transplantation Between Donors and Recipients with HIV Is Safe - Blog
HIVR4P 2024 Research Highlights: Reproductive Health While on PrEP and Signals to Guide HIV Vaccines and Cure 10-10-2024Cross-posted from: NIAID Now Blog New NIAID-supported science presented at the 2024 HIV Research for Prevent... - Blog
Defining the Goals of HIV Science Through 2034 10-02-2024Cross-posted from: NIAID Now Blog This blog is the third in a series about the future of NIAID's HIV clinical... - Blog
Recent Research News Roundup: HIV and Other Infectious Diseases 09-18-2024NIH s National Institute of Allergy and Infectious Diseases has recently shared news about mpox research, HIV risk among cisgender women, COVID in people with..… - Blog
SARS-CoV-2 Rapidly Evolves in People with Advanced HIV 09-11-2024Cross-posted from: NIAID Now NIAID Researchers Uncover How SARS-CoV-2 Variants May Emerge in People with Weak... - Blog
ICYMI: Research Roundup from AIDS 2024 08-15-2024A brief roundup of key topics of HIV.gov s coverage of AIDS 2024, including HIV prevention, cure research, and more. - Blog
We Should Leverage the Successes of HIV Care to Prevent Overdose Mortality 08-01-2024Cross-posted from: NIDA blog For complex reasons, HIV and substance use have been inextricably linked since the... - Blog
Putting People First: IAS Closing Day 07-26-2024Kaye Hayes, HHS Deputy Assistant Secretary for Infectious Disease and Director of the Office of Infectious Disease and HIV/AIDS Policy, and Francisco Ruiz, Dire… - Blog
Exploratory Analysis Associates HIV Drug Abacavir with Elevated Cardiovascular Disease Risk in Large Global Trial 07-26-2024Cross-posted from: NIAID Newsroom Transmission electron micrograph of HIV-1 virus particles (teal) budding and... - Blog
Day 4 AIDS 2024: Long-Acting Injectables, Bi-Directional Learning, PACHA & More 07-25-2024HIV.gov continues its daily livestreams from the International AIDS Conference in Munich, Germany. Today s topics include long-acting injectables, bi-directio..… - Blog
Long-Acting Injectable Cabotegravir for HIV Prevention Is Safe in Pregnancy 07-25-2024Cross-posted from: NIAID Newsroom Transmission electron micrograph of HIV-1 virus particles (green) replicatin... - Blog
Day 3 at AIDS 2024: Research Updates, HIV Criminalization Laws, and AI 07-24-2024Read updates about HIV.gov s conversations on day three of the International AIDS Conference in Munich, Germany. - Blog
Day 2 at AIDS 2024: NIH Research Updates, Inequities, U=U, and Doxy PrEP 07-23-2024Watch HIV.gov s conversations on the second day of the International AIDS Conference in Munich, Germany. - Blog
An Isolated Viral Load Test May Generate False Positive Results for People Using Long-Acting PrEP 07-23-2024Colorized transmission electron micrograph of multiple HIV-1 virus particles (green) budding from a cell projec... - Blog
Our Words Have Power—NIAID Embraces Respectful, Inclusive, and Person-First Language 06-28-2024Cross-posted from: NIAID Now Blog The power of word choice is obvious every day in my life as a researcher, c... - Blog
U.S. Clinical Trials Begin for Twice-Yearly HIV Prevention Injection 06-07-2024Cross-posted from NIAID Newsroom Colorized transmission electron micrograph of numerous HIV-1 virus particles... - Blog
An Emergency Department Screening Strategy Identifies Asymptomatic and Undiagnosed Syphilis 06-05-2024As syphilis rates continue to rise in the United States, emergency departments may be a way for people with limited healthcare access to get screening and treat… - Blog
FYI Video: A Conversation About the Importance of HIV Vaccine Research 06-05-2024Louis Shackelford of the HIV Vaccine Trials Network and NIH s Carl Dieffenbach discuss why a safe, effective, and durable HIV vaccine is important for health... - Blog
NIAID Marks HIV Vaccine Awareness Day 2024 05-17-2024Cross-posted from: NIAID Now Vaccines consistently transform public health, and HIV vaccine research has been... - Blog
Help Scientists Find a Safe and Effective Mpox Treatment 05-16-2024The STOMP trial is evaluating the antiviral drug tecovirimat (TPOXX) as a treatment for mpox. Learn how individuals, providers, and community organizations can.…